VialNAD+
500mg · Vial

Tirzepatide in 10mg, 20mg, 30mg and 40mg, vial and pen. Held in the UK and dispatched same day before 2pm.
Tirzepatide comes in 10mg, 20mg, 30mg and 40mg, as vial and pen, from £40.99. Order before 2pm on a weekday and it is dispatched the same day, tracked, and settled by bank transfer — nothing is charged automatically.
Tirzepatide is a synthetic 39-amino-acid peptide acting as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The sequence is based on the native GIP backbone rather than GLP-1, with a fatty-acid moiety supporting albumin binding. It is the reference compound against which newer multi-incretin agonists are compared in the literature.
| Form | Lyophilised powder |
|---|---|
| Net peptide content | 10mg · 20mg · 30mg · 40mg per vial |
| Appearance | White to off-white lyophilisate |
| Reconstitution | Bacteriostatic or sterile water, added by the end researcher |
| Purity | ≥99% by HPLC |
| Storage | Cool and dry, protected from light |
| Compound | Tirzepatide |
|---|---|
| Synonyms | WLZ4518; tirzepatid |
| Class | Dual GIP / GLP-1 receptor agonist; long-acting incretin analogue (39 amino acids) |
| Modification | C20 fatty diacid conjugated via a γGlu-2×OEG linker; Aib substitutions at positions 2 and 13 |
| Formula | C225H348N48O68 |
| Molecular weight | 4813 g/mol |
| CAS | 2023788-19-2 |
Formula, weight and CAS from PubChem CID 166567236.
The pen arrives pre-filled and ready to use. The vial holds lyophilised powder for reconstitution. Each carries the same compound; the difference is presentation and quantity.
Same-day dispatch before 2pm. Payment is by bank transfer — we send the bank details and your total by email once your order is placed.
Vial500mg · Vial
Vial · Pen10mg – 40mg · Vial and Pen
Vial · Capsules10mg · Vial and Capsules
Pen · Vial50mg – 100mg · Pen and Vial
Identity. Synthetic peptide engineered from the native GIP sequence, with agonist activity at both the GIP and GLP-1 receptors. Development code LY3298176; marketed as Mounjaro and Zepbound.
Unlike most of this catalogue, tirzepatide is a licensed medicine with phase 3 data. The SURMOUNT programme is the reference set, and a later head-to-head trial compared it against semaglutide.
References are to published literature and are summarised as reported by their authors, including the study model. They describe what was investigated — they are not instructions, and Peptiq supplies no usage guidance.
Tirzepatide is a research peptide supplied by Peptiq in vial and pen, in 10mg, 20mg, 30mg and 40mg. It is also listed as tirzepatid.
You can buy Tirzepatide directly from Peptiq. We are a UK supplier, we ship tracked within the UK, and orders are settled by bank transfer — the details reach you as soon as your order is placed.
10mg, 20mg, 30mg and 40mg, available as vial and pen.
Same-day dispatch before 2pm. Dispatched once payment clears.
≥99%, printed on the label alongside the compound and quantity.
Leave your name and email so we can reply if you close the page.